Literature DB >> 27210058

Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.

Koji Harada1, Tarannum Ferdous1, Toyoko Harada1, Yoshiya Ueyama1.   

Abstract

Cancer cells show enhanced glucose consumption and lactate production even in the presence of abundant oxygen, a phenomenon known as the Warburg effect, which is related to tumor proliferation, progression and drug-resistance in cancers. Hypoxia-inducible factor-1 (HIF-1) and several members of Phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway positively contribute to the Warburg effect, whereas AMP activated protein Kinase (AMPK) acts as a negative regulator. Targeting the regulator molecules of Warburg effect might be a useful strategy to effectively kill cancer cells. Metformin was reported to be effective against various cancers as it inhibits cell proliferation by activating AMPK, and inhibiting mTOR and HIF-1α. Several studies suggested the efficacy of metformin with 5-fluorouracil (5-FU) against esophageal and colon cancer. In this study, we evaluated the efficacy of metformin and 5-FU combined therapy against human oral squamous cell carcinoma (OSCC) in vitro and in vivo. MTT assay and TUNEL assay revealed that metformin (4 mg/ml) and 5-FU (2.5 µg/ml) combination treatment effectively inhibited cell growth and induced apoptosis in OSCC cell lines (HSC2, HSC3 and HSC4) compared to either agent alone. Lactate colorimetric assay detected decreased level of lactate in the supernatants of metformin and 5-FU treated cells compared to cells treated with metformin or 5-FU. Western blot analysis showed marked downregulation of HIF-1α and mTOR expression, and upregulation of AMPKα in cells treated with metformin and 5-FU combination treatment. Combination therapy with metformin (200 mg/kg, i.p.) and 5-FU (10 mg/kg, i.p.) for 4 weeks (5 days/week) effectively reduced HSC2 tumor growth (77.6%) compared to metformin (59.9%) or 5-FU (52%) alone in nude mice. These findings suggest that metformin and 5-FU combined therapy could exert strong antitumor effect against OSCC through the inhibition of Warburg phenomenon in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27210058     DOI: 10.3892/ijo.2016.3523

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  19 in total

1.  AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3.

Authors:  Ryuma Tokunaga; Shu Cao; Madiha Naseem; Francesca Battaglin; Jae Ho Lo; Hiroyuki Arai; Fotios Loupakis; Sebastian Stintzing; Alberto Puccini; Martin D Berger; Shivani Soni; Wu Zhang; Christoph Mancao; Bodour Salhia; Shannon M Mumenthaler; Daniel J Weisenberger; Gangning Liang; Chiara Cremolini; Volker Heinemann; Alfredo Falcone; Joshua Millstein; Heinz-Josef Lenz
Journal:  Int J Cancer       Date:  2019-03-26       Impact factor: 7.396

2.  Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.

Authors:  Nicola Principe; Wayne J Aston; Danika E Hope; Caitlin M Tilsed; Scott A Fisher; Louis Boon; Ian M Dick; Wee Loong Chin; Alison M McDonnell; Anna K Nowak; Richard A Lake; Jonathan Chee; Willem Joost Lesterhuis
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

3.  Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial.

Authors:  Joseph Curry; Jennifer Johnson; Patrick Tassone; Marina Domingo Vidal; Diana Whitaker Menezes; John Sprandio; Mehri Mollaee; Paolo Cotzia; Ruth Birbe; Zhao Lin; Kurren Gill; Elizabeth Duddy; Tingting Zhan; Benjamin Leiby; Michelle Reyzer; David Cognetti; Adam Luginbuhl; Madalina Tuluc; Ubaldo Martinez-Outschoorn
Journal:  Laryngoscope       Date:  2017-02-10       Impact factor: 3.325

4.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

5.  Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer.

Authors:  Yue Pan; Fan Zhang; Yawei Zhao; Dan Shao; Xiao Zheng; Yujing Chen; Kan He; Jing Li; Li Chen
Journal:  J Cancer       Date:  2017-06-05       Impact factor: 4.207

6.  Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.

Authors:  Talita Antunes Guimarães; Lucyana Conceição Farias; Eliane Sobrinho Santos; Carlos Alberto de Carvalho Fraga; Lissur Azevedo Orsini; Leandro de Freitas Teles; John David Feltenberger; Sabrin Ferreira de Jesus; Marcela Gonçalves de Souza; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; Ricardo Santiago Gomez; André Luiz Sena Guimarães
Journal:  Oncotarget       Date:  2016-08-23

7.  Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study.

Authors:  Feng Peng; Dan Hu; Xiandong Lin; Binying Liang; Ying Chen; Hejun Zhang; Yan Xia; Jinxiu Lin; Xiongwei Zheng; Wenquan Niu
Journal:  Aging (Albany NY)       Date:  2018-05-24       Impact factor: 5.682

Review 8.  Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma.

Authors:  Walaa Hamed Shaker Nasry; Chelsea K Martin
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

9.  Metformin alters therapeutic effects in the BALB/c tumor therapy model.

Authors:  Felix B Meyer; Sophie Goebel; Sonja B Spangel; Christiane Leovsky; Doerte Hoelzer; René Thierbach
Journal:  BMC Cancer       Date:  2021-05-28       Impact factor: 4.430

Review 10.  An Apoptotic and Endosymbiotic Explanation of the Warburg and the Inverse Warburg Hypotheses.

Authors:  Szymon Kaczanowski; Joanna Klim; Urszula Zielenkiewicz
Journal:  Int J Mol Sci       Date:  2018-10-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.